|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 47/00 | (2006.01) |
| (11) | Number of the document | 1861116 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06748594.6 |
| Date of filing the European patent application | 2006-03-22 | |
| (97) | Date of publication of the European application | 2007-12-05 |
| (45) | Date of publication and mention of the grant of the patent | 2015-09-16 |
| (46) | Date of publication of the claims translation | 2016-01-11 |
| (86) | Number | PCT/US2006/010600 |
| Date | 2006-03-22 |
| (87) | Number | WO 2006/104852 |
| Date | 2006-10-05 |
| (30) | Number | Date | Country code |
| 665125 P | 2005-03-25 | US |
| (72) |
DIX, Daniel, US
FRYE, Kelly, US
KAUTZ, Susan, US
|
| (73) |
REGENERON PHARMACEUTICALS, INC.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | VEGF antagonisto kompozicijos |
| VEGF ANTAGONIST FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-02-18 | 347.00 EUR |